Back to Search Start Over

Pathophysiological evaluation of the LRRK2 G2385R risk variant for Parkinson's disease.

Authors :
Tezuka T
Taniguchi D
Sano M
Shimada T
Oji Y
Tsunemi T
Ikeda A
Li Y
Yoshino H
Ogata J
Shiba-Fukushima K
Funayama M
Nishioka K
Imai Y
Hattori N
Source :
NPJ Parkinson's disease [NPJ Parkinsons Dis] 2022 Aug 05; Vol. 8 (1), pp. 97. Date of Electronic Publication: 2022 Aug 05.
Publication Year :
2022

Abstract

Missense variants in leucine-rich repeat kinase 2 (LRRK2) lead to familial and sporadic Parkinson's disease (PD). The pathological features of PD patients with LRRK2 variants differ. Here, we report an autopsy case harboring the LRRK2 G2385R, a risk variant for PD occurring mainly in Asian populations. The patient exhibited levodopa-responsive parkinsonism at the early stage and visual hallucinations at the advanced stage. The pathological study revealed diffuse Lewy bodies with neurofibrillary tangles, amyloid plaques, and mild signs of neuroinflammation. Biochemically, detergent-insoluble phospho-α-synuclein was accumulated in the frontal, temporal, entorhinal cortexes, and putamen, consistent with the pathological observations. Elevated phosphorylation of Rab10, a substrate of LRRK2, was also prominent in various brain regions. In conclusion, G2385R appears to increase LRRK2 kinase activity in the human brain, inducing a deleterious brain environment that causes Lewy body pathology.<br /> (© 2022. The Author(s).)

Details

Language :
English
ISSN :
2373-8057
Volume :
8
Issue :
1
Database :
MEDLINE
Journal :
NPJ Parkinson's disease
Publication Type :
Academic Journal
Accession number :
35931783
Full Text :
https://doi.org/10.1038/s41531-022-00367-y